SleepCogni Revenue and Competitors

Sheffield,

Location

$4.1M

Total Funding

Estimated Revenue & Valuation

  • SleepCogni's estimated annual revenue is currently $1.3M per year.(i)
  • SleepCogni's estimated revenue per employee is $125,500
  • SleepCogni's total funding is $4.1M.

Employee Data

  • SleepCogni has 10 Employees.(i)
  • SleepCogni grew their employee count by 0% last year.

SleepCogni's People

NameTitleEmail/Phone
1
Founder & CSOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is SleepCogni?

SleepCogni is a British award-winning first-in-class medical device for the diagnosis and treatment of sleep disorders. SleepCogni’s patented bedside and wearable device system helps sleep professionals better understand insomniacs and offers a range of proven interventions, such as CBT-I. We offer a comprehensive digital and technological solution integrating information on physiology, behaviour and the sleeping environment. We are funded by one of the UK's leading venture capital funds, Mercia Technologies Plc and more recently by the UK’s governmental Innovation agency, InnovateUK. We are working with some of the worlds' leading technologists, sleep clinicians and universities. Currently, we are moving from our research & development phase towards clinically validating our device’s measurements, before moving onto clinical trials in 2018. Our team is passionate and dedicated to make a difference globally by solving a surprisingly common problem many (1 in 3) people face: trouble sleeping.

keywords:N/A

$4.1M

Total Funding

10

Number of Employees

$1.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.1M100%N/A
#2
$1.5M10-29%N/A
#3
$0.9M10N/AN/A
#4
$15M10-37%N/A
#5
$1.3M11-35%N/A